Promising Research – Cannabis Potentially Blocks COVID-19
Canna Global Investments Plc. has identified promising research with preliminary evidence that cannabis can potentially block the COVID-19 infection.
Medical cannabis product approved for epilepsy
The EU has approved for the first time the use of a medicinal cannabis product aimed at patients with two rare, but severe, forms of childhood epilepsy.
Cannabis chemical may have 'major impact' on pancreatic cancer treatment
Cannabis chemical may help pancreatic cancer, study finds.
Miracle Medicine or Dangerous Drug? review – weeding out the truth
This documentary on the pleasurable highs and puritanical prejudices around cannabis use was lively and educational
Colorado has made more than $1bn from legal marijuana industry
Colorado has made more than $1bn (£789m) since it legalised marijuana in 2014, with more than 41,000 people
Chart: Diversification enhances profitability of marijuana product manufacturers – to an extent
Makers of cannabis products are more likely to turn a profit if they offer merchandise across multiple categories
Utilizing Legal Cannabis For Sustainable Stimulus Begins Taking Root In Africa
Africa has seen an accelerating wave of cannabis reform over the past 24 months, much of the movement so far anchored to the south
VLOGS
CGI PLC is creating a portfolio of cannabis and hemp-related Intellectual Property assets that meet clear commercial needs which offer our shareholders best-in-class returns. CGI’s long term strategy is to be the global leader in the production of medical, recreational cannabinoid extracts, oils, nutraceuticals, and pharmaceuticals with a solid set of highly developed IP assets. These assets will be licensed to companies capable of delivering our revolutionary cannabis based products to the global market place.
Quick Links
Contact Us
Address:
Devonshire House, 1st Floor, 1 Mayfair Place,
London, W1J 8AJ, United Kingdom Email: info@cgiplc.co.uk